IQVIA HOLDINGS INC
NYSE: IQV (IQVIA Holdings, Inc.)
Kemas kini terakhir: 16 jam lalu163.85
-5.55 (-3.28%)
| Penutupan Terdahulu | 169.40 |
| Buka | 167.58 |
| Jumlah Dagangan | 1,526,946 |
| Purata Dagangan (3B) | 2,042,408 |
| Modal Pasaran | 27,805,345,792 |
| Harga / Pendapatan (P/E TTM) | 20.90 |
| Harga / Pendapatan (P/E Ke hadapan) | 13.14 |
| Harga / Jualan (P/S) | 1.77 |
| Harga / Buku (P/B) | 4.29 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2026 |
| Margin Keuntungan | 7.88% |
| Margin Operasi (TTM) | 13.39% |
| EPS Cair (TTM) | 6.89 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -26.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 272.12% |
| Nisbah Semasa (MRQ) | 0.840 |
| Aliran Tunai Operasi (OCF TTM) | 2.62 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.45 B |
| Pulangan Atas Aset (ROA TTM) | 5.16% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.79% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | IQVIA Holdings, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.50 |
|
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 1.05% |
| % Dimiliki oleh Institusi | 98.21% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Longview Partners (Guernsey) Ltd | 31 Dec 2025 | 2,220,424 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 255.00 (Jefferies, 55.63%) | Beli |
| Median | 221.00 (34.88%) | |
| Rendah | 200.00 (Citigroup, 22.06%) | Pegang |
| Purata | 225.44 (37.59%) | |
| Jumlah | 8 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 181.53 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| TD Cowen | 09 Mar 2026 | 213.00 (30.00%) | Beli | 178.55 |
| 22 Jan 2026 | 245.00 (49.53%) | Pegang | 239.05 | |
| Barclays | 06 Mar 2026 | 210.00 (28.17%) | Beli | 174.49 |
| 06 Feb 2026 | 210.00 (28.17%) | Pegang | 187.49 | |
| RBC Capital | 03 Mar 2026 | 221.00 (34.88%) | Beli | 173.96 |
| Truist Securities | 19 Feb 2026 | 245.00 (49.53%) | Beli | 169.36 |
| 08 Jan 2026 | 290.00 (76.99%) | Beli | 243.19 | |
| Citigroup | 06 Feb 2026 | 200.00 (22.06%) | Pegang | 187.49 |
| JP Morgan | 06 Feb 2026 | 225.00 (37.32%) | Beli | 187.49 |
| Jefferies | 06 Feb 2026 | 255.00 (55.63%) | Beli | 187.49 |
| Stifel | 06 Feb 2026 | 220.00 (34.27%) | Beli | 187.49 |
| UBS | 06 Feb 2026 | 240.00 (46.48%) | Beli | 187.49 |
| 08 Jan 2026 | 280.00 (70.89%) | Beli | 243.19 | |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance |
| 29 Jan 2026 | Pengumuman | IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration |
| 22 Jan 2026 | Pengumuman | IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year |
| 20 Jan 2026 | Pengumuman | IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |